Thursday, June 18, 2026
HomeIndustriesBiotechnology

Biotechnology

Leap Therapeutics to Present Positive New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab

Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, announced the Company will be presenting updated data from the DisTinGuish...

ImmunityBio Announces Results of Phase 2 Metastatic Pancreatic Cancer Trial

ImmunityBio, Inc, a clinical-stage immunotherapy company, announced interim results (N=63) in its metastatic pancreatic cancer trial (QUILT 88) showing that the overall survival rate...

Neurimmune expands drug discovery collaboration with Ono Pharmaceutical

Neurimmune AG announced that it has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. The collaboration is focused on creating...

Halo Labs Launches New Instruments for Protein, Cell, and Gene Therapy Developers

Halo Labs, a life science instrumentation company developing tools for biologics researchers, announced that it has launched its latest products - Aura+™and Aura PTx™. Also...

WuXi Biologics Completes Inspection by South Korea’s Ministry of Food and Drug Safety

WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by...

Hot Topics